Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Caravatta, Luciana ^a   Sallustio, Giuseppina ^a   Pacelli, Fabio ^a   Padula, Gilbert D A ^b   Deodato, Francesco ^a   Macchia, Gabriella ^a   Massaccesi, Mariangela ^a   Picardi, Vincenzo ^a   Cilla, Savino ^a   Marinelli, Alfonso ^a   Cellini, Numa ^c   Valentini, Vincenzo ^c   Morganti, Alessio G ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b Saint Mary's Health Care   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Clinical target volume; Pancreatic cancer; Radiotherapy

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PREOPERATIVE RADIOTHERAPY; VASCULARIZATION;

ANATOMIC LANDMARKS; HUMANS; LYMPH NODES; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861972825     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-86     Document Type: Article

References (40)

1. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996, 223:273-279. 10.1097/00000658-199603000-00007, 1235115, 8604907.
2. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987, 59:2006-2010. Gastrointestinal Tumor Study Group.
3. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection for the cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 1999, 230:776-784. 10.1097/00000658-199912000-00006, 1420941, 10615932.
4. Khanna A, Walker GR, Livingstone AS, Arheart KL, Rocha-Lima C, Koniaris LG. Is adjuvant 5-FU based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question. J Gastrointest Surg 2006, 10:689-697. 10.1016/j.gassur.2005.11.006, 16713541.
5. Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Neoptolemos JP, . Pancreatic Cancer Meta-analysis Group Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005, 92:1372-1381. 10.1038/sj.bjc.6602513, 2361989, 15812554, Pancreatic Cancer Meta-analysis Group.
6. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004, 363:1049-1057. 10.1016/S0140-6736(04)15841-8, 3062508, 15051286.
7. Morganti AG, Massaccesi M, La Torre G, Caravatta L, Piscopo A, Tambaro R, Sofo L, Sallustio G, Ingrosso M, Macchia G, Deodato F, Picardi V, Ippolito E, Cellini N, Valentini V. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 2010, 17:194-205. 10.1245/s10434-009-0762-4, 19856029.
8. National Comprehensive Cancer Network Inc Practice Guidelines in Oncology. - Version 2.2011: Pancreatic Adenocarcinoma. v. 2. 2011 2011, Jentintown, PA: National Comprehensive Cancer Network, Inc, National Comprehensive Cancer Network.
9. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000, 4:567-579. 10.1016/S1091-255X(00)80105-5, 11307091.
10. Yoshida T, Matsumoto T, Sasaki A, Shibata K, Aramaki M, Kitano S. Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 2004, 187:736-740. 10.1016/j.amjsurg.2003.07.031, 15191867.
11. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. Lymphatic flow in carcinoma of the distal bile duct based on a clinicopathologic study. Cancer 1993, 72:2112-2117. 10.1002/1097-0142(19931001)72:7<2112::AID-CNCR2820720709>3.0.CO;2-X, 8374870.
12. Morganti AG, Valentini V, Macchia G, Alfieri S, Trodella L, Brizi MG, Bossola M, Ziccarelli L, Doglietto GB, Cellini N. Adjuvant radiotherapy in resectable pancreatic carcinoma. Eur J Surg Oncol 2002, 28:523-530. 10.1053/ejso.2002.1289, 12217306.
13. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 2006, 10:511-518. 10.1016/j.gassur.2005.09.016, 16627216.
14. Turrini O, Viret F, Moureau-Zabotto L, Guiramand J, Moutardier V, Lelong B, de Chaisemartin C, Giovannini M, Delpero JR. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience. Oncology 2009, 76:413-419. 10.1159/000215928, 19407474.
15. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008, 26:3487-3495. 10.1200/JCO.2007.15.8642, 18640929.
16. Metha VK. Radiation oncology: an evidence-based approach. 2008, Springer-Verlag: Berlin Heidelberg, Lu JJ, Brady LW.
17. Petit SF, Wu B, Kazhdan M, Dekker A, Simari P, Kumar R, Taylor R, Herman JM, McNutt T. Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma. Radiother Oncol 2012, 102:38-44. 10.1016/j.radonc.2011.05.025, 21680036.
18. van der Geld YG, van Triest B, Verbakel WF, Van Sörnsen De Koste JR, Senan S, Slotman BJ, Lagerwaard FJ. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. Int J Radiat Oncol Biol Phys 2008, 72:1215-1220. 10.1016/j.ijrobp.2008.07.010, 18954715.
19. Brunner TB, Merkel S, Grabenbauer GG, Meyer T, Baum U, Papadopoulos T, Sauer R, Hohenberger W. Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis. Int J Radiat Oncol Biol Phys 2005, 62:1021-1029. 10.1016/j.ijrobp.2004.12.018, 15990004.
20. Morganti AG, Cellini N, Mattiucci GC, Macchia G, Smaniotto D, Luzi S, Balducci M, Deodato F, Valentini V, Trodella L. Lymphatic drainage and CTV in pancreatic carcinoma. Rays 2003, 28:311-315.
21. Atlan D, Mornex F. Radiotherapy of cancers of the pancreas and extrahepatic biliary tree. Gross tumor volume (GTV). Clinical target volume (CTV). Cancer Radiother 2001, 5:534-541. 10.1016/S1278-3218(01)00129-9, 11715305.
22. Abrams RA, Regine WF, Goodman KA, Dawson AL, Ben-Josef E, Haustermans K, Bosch WR, Turian J. Consensus Panel Contouring Atlas for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Cancer
23. Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 1978, 41:880-887. 10.1002/1097-0142(197803)41:3<880::AID-CNCR2820410315>3.0.CO;2-J, 638975.
24. Deki H, Sato T. An anatomic study of the peripancreatic lymphatics. Surg Radiol Anat 1988, 10:121-135. 10.1007/BF02307820, 3135617.
25. Kayahara M, Nagakawa T, Kobayashi H, Mori K, Nakano T, Kadoya N, Ohta T, Ueno K, Miyazaki I. Lymphatic flow in carcinoma of the head of the pancreas. Cancer 1992, 70:2061-2066. 10.1002/1097-0142(19921015)70:8<2061::AID-CNCR2820700808>3.0.CO;2-V, 1327485.
26. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Ueno K, Tajima H, Elnemr A, Miwa K. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery?. Cancer 1999, 85:583-590. 10.1002/(SICI)1097-0142(19990201)85:3<583::AID-CNCR8>3.0.CO;2-J, 10091731.
27. Noto M, Miwa K, Kitagawa H, Kayahara M, Takamura H, Shimizu K, Ohta T. Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 2005, 29:1056-1061.
28. Yi SQ, Miwa K, Ohta T, Kayahara M, Kitagawa H, Tanaka A, Shimokawa T, Akita K, Tanaka S. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer. Pancreas 2003, 27:225-229. 10.1097/00006676-200310000-00005, 14508126.
29. Jin G, Sugiyama M, Tuo H, Oki A, Abe N, Mori T, Masaki T, Fujioka Y, Atomi Y. Distribution of lymphatic vessels in the neural plexuses surrounding the superior mesenteric artery. Pancreas 2006, 32:62-66. 10.1097/01.mpa.0000194607.16982.d7, 16340746.
30. Borghi F, Gattolin A, Garbossa D, Bogliatto F, Garavoglia M, Levi AC. Embryologic bases of extended radical resection in pancreatic cancer. Arch Surg 1998, 133:297-301. 10.1001/archsurg.133.3.297, 9517744.
31. Sun W, Leong CN, Zhang Z, Lu JJ. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence. Radiat Oncol 2010, 5:28. 10.1186/1748-717X-5-28, 2859771, 20398316.
32. Japan Pancreas Society Classification of pancreatic carcinoma 2003, Tokyo: Kanehara, 2nd English, Japan Pancreas Society.
33. Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Miyazaki I. Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas. Cancer 1994, 73:1155-1162. 10.1002/1097-0142(19940215)73:4<1155::AID-CNCR2820730406>3.0.CO;2-H, 8313317.
34. Morganti AG, Trodella L, Valentini V, Barbi S, Macchia G, Mantini G, Turriziani A, Cellini N. Pain relief with short-term irradiation in locally advanced carcinoma of the pancreas. J Palliat Care 2003, 19:258-262.
35. Morganti AG, Trodella L, Valentini V, Macchia G, Alfieri S, Smaniotto D, Luzi S, Costamagna G, Doglietto GB, Cellini N. Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study. Onkologie 2003, 26:325-329. 10.1159/000072089, 12972696.
36. Ito Y, Okusaka T, Kagami Y, Ueno H, Ikeda M, Sumi M, Imai A, Fujimoto N, Ikeda H. Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer. Anticancer Res 2006, 26:3755-3759.
37. Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1604-1612. 10.1016/j.ijrobp.2005.05.062, 16198509.
38. Perez CA, Brady L. Principles and practice of radiation oncology 1998, Philadelphia: Lippincott-Raven Publishers, 3.
39. Song YC, You JQ, Yuan ZY, Wang W, Li XY, Wang P. A preliminary probe into the movement of pancreatic lesions and factors that influence it. Br J Radiol 2010, 83:505-508. 10.1259/bjr/17111751, 3473595, 20505031.
40. Yamazaki H, Nishiyama K, Tanaka E, Koiwai K, Shikama N, Ito Y, Arahira S, Tamamoto T, Shibata T, Tamaki Y, Kodaira T, Oguchi M. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. Anticancer Res 2007, 27:2965-2971.